首页> 外文OA文献 >Antimicrobial Susceptibility Testing of Neisseria Gonorrhoeae Isolates in Pakistan by Etest Compared to Calibrated Dichotomous Sensitivity and Clinical Laboratory Standards Institute Disc Diffusion Techniques.
【2h】

Antimicrobial Susceptibility Testing of Neisseria Gonorrhoeae Isolates in Pakistan by Etest Compared to Calibrated Dichotomous Sensitivity and Clinical Laboratory Standards Institute Disc Diffusion Techniques.

机译:巴斯特氏菌对淋病奈瑟菌的抗菌药敏试验与Etest相比,校准二分法敏感性和临床实验室标准研究所椎间盘扩散技术。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background Accurate detection of Neisseria gonorrhoeae antimicrobial resistance is essential for appropriate management and prevention of spread of infection in the community. In this study Calibrated Dichotomous Sensitivity (CDS) and Clinical Laboratory Standards Institute (CLSI) disc diffusion methods were compared with minimum inhibitory concentration (MIC) by Etest in Neisseria gonorrhoeae isolates from Karachi, Pakistan. CDS and CLSI disc diffusion techniques, and Etest for ceftriaxone, penicillin G, spectinomycin and ciprofloxacin against 100 isolates from years 2012–2014 were performed. Due to lack of CLSI breakpoints for azithromycin, it was interpreted using cut-offs from British Society of Antimicrobial Chemotherapy (BSAC). Due to lack of low concentration tetracycline discs, tetracycline was tested with CLSI disc diffusion and Etest only. Comparisons were based on the identified susceptibility, intermediate susceptibility and resistance (SIR) categories using the different methods. Complete percent agreement was percentage agreement achieved when test and reference method had identical SIR-category. Essential percent agreement was percentage agreement when minor discrepancies were disregarded. Results There was 100 % and 99 % overall essential agreement and 50 % versus 23 % overall complete agreement by CDS and CLSI methods, respectively, with MICs for all tested antibiotics. Using either method, there was 100 % complete agreement for ceftriaxone and spectinomycin. There was 90 % versus 86 % complete agreement for ciprofloxacin, and 60 % and 75 % for penicillin using CDS and CLSI method, respectively. Essential agreement of 99 % and complete agreement of 62 % was found for tetracycline with CLSI method. There was 100 % essential and complete agreement by CDS, BSAC and Etest for azithromycin. Conclusion No major errors with regard to identified SIR-categories were found for penicillin, ciprofloxacin, ceftriaxone and spectinomycin using CLSI and CDS methods. All isolates were susceptible to ceftriaxone and spectinomycin, and 99 % to azithromycin. In low-resource settings, both the CLSI and CDS disc diffusion techniques might be used for susceptibility testing of gonococcal isolates. However, these methods require considerable standardization and quality controls for adequate levels of reproducibility and correct interpretation to reflect appropriately the MIC values of the different antimicrobials. New, emerging, or rare resistance should be confirmed by MIC determination. Keywords Antimicrobial surveillance Neisseria gonorrhoeae CDS CLSI Disc diffusion Etest
机译:背景技术正确检测淋病奈瑟氏菌的抗菌素耐药性对于适当管理和预防社区感染的传播至关重要。在这项研究中,通过Etest对来自巴基斯坦卡拉奇的淋病奈瑟氏球菌分离株的校准二分敏感性(CDS)和临床实验室标准协会(CLSI)光盘扩散方法与最低抑菌浓度(MIC)进行了比较。进行了CDS和CLSI光盘扩散技术以及针对2012年至2014年的100株分离物的头孢曲松,青霉素G,壮观霉素和环丙沙星的Etest试验。由于缺乏阿奇霉素的CLSI断裂点,因此使用了英国抗微生物化学疗法协会(BSAC)的临界值对其进行了解释。由于缺乏低浓度的四环素光盘,因此仅使用CLSI光盘扩散和Etest测试了四环素。比较是基于使用不同方法确定的药敏性,中间药敏性和耐药性(SIR)类别进行的。当测试方法和参考方法具有相同的SIR类别时,完成百分比协议即为达成百分比协议。基本百分比协议是在忽略微小差异时的百分比协议。结果通过CDS和CLSI方法,对于所有测试的抗生素,MIC分别达到100%和99%的总体必要一致性,而50%和23%的总体完全一致性。使用任何一种方法,头孢曲松和壮观霉素的百分百完全一致。使用CDS和CLSI方法,环丙沙星的完全一致率为90%,而86%为完全一致,青霉素的完全一致率为60%和75%。用CLSI法测得四环素的基本一致性为99%,完全一致性为62%。 CDS,BSAC和Etest已就阿奇霉素达成了100%必要且完全的协议。结论使用CLSI和CDS方法未发现青霉素,环丙沙星,头孢曲松和壮观霉素的SIR类别存在重大错误。所有分离株均对头孢曲松和壮观霉素敏感,对阿奇霉素敏感99%。在资源贫乏的地区,CLSI和CDS光盘扩散技术都可以用于淋球菌分离株的药敏试验。但是,这些方法需要大量的标准化和质量控制,以确保足够的可重复性水平和正确的解释,以正确反映不同抗生素的MIC值。新的,新兴的或罕见的耐药性应通过MIC测定来确认。关键词抗菌监测淋病奈瑟菌CDS CLSI盘片扩散Etest

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号